IMPALA Consortium is pleased to announce the release of its newest open-source R Package, the Clinical Trial Anomaly Spotter (CTAS.) CTAS is a powerful tool for Central Statistical Monitoring that identifies outliers and anomalies efficiently and accurately in clinical trial [...]
On November 9, 2023, IMPALA hosted a webinar on Embedding an Open Source Package into Analytics-Based Audits. During this presentation, Bjoern Koneswarakantha and Lisa Bennett of Roche discussed IMPALA’s Clinical Safety Reporting R package. This included testing, methodology, cross-validation between [...]
9 November, 2023, 5pm CET/ 11am EST IMPALA welcomes you to it's webinar on November 9th on Embedding an Open Source Package into Analytics-Based Audits. During this presentation, IMPALA's Clinical Safety Reporting R package will be discussed, including testing, methodology, [...]
The DIA Global Meeting held in Boston from June 25-29, 2023, brought together professionals from the pharmaceutical industry, regulatory agencies, and research organisations. IMPALA was grateful to have a great delegation of members and to have three sessions to showcase some [...]
In the first few months since its launch, the Inter coMPany quALity Analytics (IMPALA) Consortium welcomes its newest BioPharma members: Amgen, AstraZeneca, Eli Lilly and Company, GSK, Galapagos, and Sanofi. IMPALA officially launched in October 2022 as a member program [...]
